🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this single arm, open label, phase 2 trial, operable patients with stage...
Status
Unknown
Location
Yantai Yuhuangding Hospital
Start Date
2022-08-04
Trial ID
NCT05800756
Treatments Being Tested
This study is a prospective, single-arm, phase II clinical study for patien...
Status
Unknown
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05577923
Treatments Being Tested
This study investigates the efficacy and safety of trastuzumab, pyrotinib c...
Status
Unknown
Location
Multiple Locations
Start Date
2022-10-20
Trial ID
NCT05577442
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This study is an open-label, biomarker-integrated umbrella trial designed t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07653451
Treatments Being Tested
The purpose of this study is to determine if the triplet combination of dal...
Status
Unknown
Location
Tianjin Cancer Hospital
Start Date
2023-05
Trial ID
NCT05806671
Treatments Being Tested
NOAH study confirmed that trastuzumab combined with chemotherapy can signif...
Status
Recruiting
Location
Shengjing Hospital of China Medical University
Start Date
2022-02-10
Trial ID
NCT05228951
Treatments Being Tested
Breast cancer is the most common malignancy in women, with approximately 20...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-20
Trial ID
NCT07307287
Treatments Being Tested
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Recruiting
Location
Department of GI Oncology, Peking University Cancer Hospital,
Start Date
2024-11-01
Trial ID
NCT06684600
Treatments Being Tested
This is a a multicenter Phase II clinical study investigating efficacy of p...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2023-02-01
Trial ID
NCT07014410
Treatments Being Tested